Biotech

All Articles

Ultragenyx tweaks genetics therapy application to dial up effectiveness

.A minority of people taking Ultragenyx Pharmaceutical's Wilson illness genetics therapy UX701 have ...

Biopharma unemployment cost maintains in Q3: Fierce Biotech evaluation

.As summer months warm looks to cool down winds, hopes that this year would deliver extensive field ...

J &amp J loses stage 2 dengue prospect in most recent switch coming from vaccines

.Johnson &amp Johnson's deprioritization of its transmittable condition pipe has actually asserted y...

Relay drops 10% of personnel after earlier cutbacks in July

.Accuracy medicine biotech Relay Therapies is losing approximately 10% of its own staff in efforts t...

Pentixapharm scores $22M IPO to deposit radiopharma tests

.Pentixapharm has actually introduced just about twenty million europeans ($ 22 thousand) coming fro...

Lundbeck faucets Charles Stream for AI-enabled neuro drug discovery

.Lundbeck has actually utilized Charles Stream Laboratories' expert system functionalities to assist...

Big pharma, biotech 'won't necessarily be symbiotic' in artificial intelligence: S&ampP

.Big Pharma is actually investing highly in artificial intelligence to slash growth timelines and fo...

I &amp I biotech Triveni elevates $115M for preclinical antibodies

.Triveni Bio has roped in $115 million in set B funds to accelerate preclinical antibody courses cre...

IGM turns coming from cancer cells to autoimmune, agitating C-suite

.IGM Biosciences finished last year laying off workers as well as improving its cancer cells pipe. C...

Shattuck centers CD47 course over unstable efficiency records, gives up 40% of personnel and sheds Ono handle

.Shattuck Labs has knocked yet another nail right into the coffin of CD47. After seeing a "small" ef...